SCNX Q1 2026 Earnings Narrowerthanexpected loss drives positive surprise despite revenue absence ANRO Q1 2026 Earnings Significant EPS Miss Highlights EarlyStage Development Costs Sensei Biotherapeutics SNSE Q1 2026 Earnings Massive EPS Miss Overshadowed by Upbeat Sentiment RWTN Q1 2026 Earnings EPS Falls Short of Estimates but Shares Edge Higher Talphera Inc TLPH Q1 2026 Earnings Narrower Loss Surprises Analysts as Company Advances Pipeline National Storage Affiliates Trust NSA Holds Steady Near 43 Amid Modest Gains Elemental Royalty Corporation ELE Holds Ground Near Resistance Key Levels in Focus Beam Therapeutics BEAM Rises 35 as Gene Editing Sector Gains Traction Moderna MRNA Slips Amid Mixed Technical Signals Key Levels to Watch AZN Q1 2026 Earnings EPS Falls Slightly Short of Consensus Stock Edges Lower